4//SEC Filing
Shukla Sanjay 4
Accession 0001209191-23-054976
CIK 0001339970other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:11 PM ET
Size
7.0 KB
Accession
0001209191-23-054976
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Shukla Sanjay
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2023-11-10$1.14/sh+1,422$1,618→ 77,595 total - Purchase
Common Stock
2023-11-13$1.11/sh+13,578$15,085→ 91,173 total
Footnotes (2)
- [F1]Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.13 to $1.14 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- [F2]Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.09 to $1.13 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001671026
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 4:11 PM ET
- Size
- 7.0 KB